Status:
COMPLETED
Monitoring Patients for Developing Communicable and Opportunistic Infections and for Responding to Therapy
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Communicable Diseases
Opportunistic Infections
Eligibility:
All Genders
Brief Summary
Patients are exposed to infectious agents regularly, regardless of their immunologic status. Traditionally clinicians have decided to institute prophylaxis based on epidemiologic factors, skin test (i...
Detailed Description
Patients are exposed to infectious agents regularly, regardless of their immunologic status. Traditionally clinicians have decided to institute prophylaxis based on epidemiologic factors, skin test (i...
Eligibility Criteria
Patients older than 18 years of age.
Ability to give informed consent.
No medical contraindication to phlebotomy.
Epidemiologically at risk for tuberculosis or for an opportunistic infection.
Patients who can identify a responsible health care provider as someone willing to provide clinical information and to receive medically important information.
Key Trial Info
Start Date :
August 1 1995
Trial Type :
OBSERVATIONAL
End Date :
October 1 2000
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00001477
Start Date
August 1 1995
End Date
October 1 2000
Last Update
March 4 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute of Allergy and Infectious Diseases (NIAID)
Bethesda, Maryland, United States, 20892